Stephen M. Ansell, MD, PhD, on Hematologic Malignancies: Immunotherapy Update

2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Stephen M. Ansell, MD, PhD, of the Mayo Clinic, discusses integrating immune checkpoint inhibitors, improving efficacy, and reducing toxicity when treating blood cancers.

Advertisement

Advertisement



Advertisement